International Journal of Women''s Dermatology最新文献

{"title":"A case of inflammatory linear verrucous epidermal nevus of the vulva.","authors":"Monika Bapna, Sarah Corley","doi":"10.1097/JW9.0000000000000269","DOIUrl":"10.1097/JW9.0000000000000269","url":null,"abstract":"","PeriodicalId":53478,"journal":{"name":"International Journal of Women''s Dermatology","volume":"12 2","pages":"e269"},"PeriodicalIF":3.0,"publicationDate":"2026-06-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13308922/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148347374","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"New hair, new rash: is there a correlation?","authors":"Mallory A Von Lotten, Tiffany T Mayo","doi":"10.1097/JW9.0000000000000271","DOIUrl":"10.1097/JW9.0000000000000271","url":null,"abstract":"","PeriodicalId":53478,"journal":{"name":"International Journal of Women''s Dermatology","volume":"12 2","pages":"e271"},"PeriodicalIF":3.0,"publicationDate":"2026-06-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13308900/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148347393","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Sequential use of fractional 10600 nm CO₂ and 1540 nm laser for the treatment of labia majora: a minimally invasive synergistic approach to vulval rejuvenation.","authors":"Catarina Capela Herz, Laura Pieri, Irene Fusco","doi":"10.1097/JW9.0000000000000265","DOIUrl":"10.1097/JW9.0000000000000265","url":null,"abstract":"","PeriodicalId":53478,"journal":{"name":"International Journal of Women''s Dermatology","volume":"12 2","pages":"e265"},"PeriodicalIF":3.0,"publicationDate":"2026-06-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13308911/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148347315","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Safety and clinical considerations of alopecia therapies during pregnancy, fertility treatment, and polycystic ovary syndrome workup.","authors":"Anna L Brinks, Carli Needle Lawrence, Caitlin A Kearney, Grace Rachko, Amy K Bieber, Shannon DeVore, Jerry Shapiro, Kristen I Lo Sicco, Daniela Majerson","doi":"10.1097/JW9.0000000000000275","DOIUrl":"10.1097/JW9.0000000000000275","url":null,"abstract":"<p><strong>Objective: </strong>To evaluate the safety of alopecia treatments during pregnancy, in-vitro fertilization (IVF), and polycystic ovary syndrome (PCOS) workup, with a focus on potential maternal and fetal risks.</p><p><strong>Data sources: </strong>A comprehensive literature search was conducted across PubMed, Web of Science, and Scopus from November 2024 to December 2024. Search terms included medication names in combination with \"pregnancy,\" \"IVF,\" \"in-vitro fertilization,\" and \"PCOS.\"</p><p><strong>Study selection: </strong>Peer-reviewed studies addressing the use of therapies for androgenetic alopecia, alopecia areata, and scarring alopecias in the contexts of pregnancy, IVF, and PCOS were included. Articles evaluating maternal safety, fetal risks, and treatment timing were prioritized. Only English-language publications were reviewed.</p><p><strong>Results: </strong>Despite increasing therapeutic options for alopecia, significant knowledge gaps remain regarding their safety during pregnancy. Pregnant women are often excluded from clinical trials, leading to a reliance on older treatments with limited data on dosing or pharmacokinetics in the pregnant population. Unfortunately, there are few alopecia medications with robust safety data in pregnancy, and many medications are contraindicated during this period. Some medications may be used with caution, while others require additional investigation. During IVF, there are alopecia medications with potential benefit in women experiencing implantation failure or PCOS. For patients undergoing PCOS workup, some alopecia medications may impact hormonal labs or mask PCOS symptoms.</p><p><strong>Conclusion: </strong>There is a critical need for more targeted research on alopecia treatments in pregnancy, IVF, and PCOS contexts. This review provides current evidence to guide clinicians and support informed, individualized treatment decisions during this vulnerable period.</p>","PeriodicalId":53478,"journal":{"name":"International Journal of Women''s Dermatology","volume":"12 2","pages":"e275"},"PeriodicalIF":3.0,"publicationDate":"2026-06-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13308938/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148347321","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Schweninger-Buzzi anetoderma with rare facial presentation: a case report.","authors":"Nandita Gawande, Sudhir Singh, Sugat Jawade, Sabiha Quazi, Mugdha Kolambe","doi":"10.1097/JW9.0000000000000292","DOIUrl":"10.1097/JW9.0000000000000292","url":null,"abstract":"","PeriodicalId":53478,"journal":{"name":"International Journal of Women''s Dermatology","volume":"12 2","pages":"e292"},"PeriodicalIF":3.0,"publicationDate":"2026-06-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13308926/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148347404","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Rituximab for autoimmune blistering diseases in pregnancy and children: a clinical review.","authors":"Henry Tseng, John W Frew, Dédée F Murrell","doi":"10.1097/JW9.0000000000000270","DOIUrl":"10.1097/JW9.0000000000000270","url":null,"abstract":"<p><strong>Objective: </strong>To critically review the current literature on the safety, efficacy, and clinical considerations of rituximab use in pediatric and pregnant patients with autoimmune blistering diseases (AIBD).</p><p><strong>Data sources: </strong>A comprehensive literature search was conducted using PubMed and Embase to identify relevant articles, including case reports, case series, observational studies, and systematic reviews.</p><p><strong>Study selections: </strong>Studies were selected based on relevance to rituximab use in pediatric and antenatal AIBD, with particular focus on treatment efficacy, adverse outcomes, and long-term immunologic effects.</p><p><strong>Results: </strong>Rituximab demonstrates promising efficacy in pediatric AIBD, though concerns remain regarding persistent hypogammaglobulinemia and delayed immune reconstitution. In regards to pregnant patients, current data do not suggest a consistent association between rituximab exposure and congenital anomalies or serious neonatal complications, particularly when used preconception or early in gestation. Reported neonatal B-cell depletion has been transient. Multidisciplinary oversight is critical given the clinical complexity of these populations.</p><p><strong>Conclusion: </strong>Rituximab may be a viable corticosteroid-sparing option for severe or refractory AIBD in children and pregnant women. Its use should be individualized and carefully monitored by experienced multidisciplinary teams. Larger prospective studies are needed to inform evidence-based guidelines.</p>","PeriodicalId":53478,"journal":{"name":"International Journal of Women''s Dermatology","volume":"12 2","pages":"e270"},"PeriodicalIF":3.0,"publicationDate":"2026-06-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13308915/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148347382","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Global barriers to sexual health, pregnancy, and breastfeeding in hidradenitis suppurativa.","authors":"Leandra A Barnes, Fatuma-Ayaan B Rinderknecht, Jennifer L Hsiao, Haley B Naik","doi":"10.1097/JW9.0000000000000261","DOIUrl":"10.1097/JW9.0000000000000261","url":null,"abstract":"<p><strong>Background: </strong>The impact of hidradenitis suppurativa (HS) on sexual health, pregnancy, and breastfeeding in female patients is understudied.</p><p><strong>Objective: </strong>To characterize the impact of HS on sexual health, barriers to breastfeeding, and barriers to accessing care for HS during breastfeeding and pregnancy.</p><p><strong>Methods: </strong>A cross-sectional survey of self-identified adult women with HS from June 13, 2021 to June 30, 2021 was performed to assess associations between demographic and clinical factors, including age, gender, race, and ethnicity, disease severity (patient global assessment), and difficulty accessing dermatologic care with the outcomes of sexual health-related quality of life, breastfeeding practices, and barriers to care.</p><p><strong>Results: </strong>Eight hundred eight eligible female respondents resided in 5 countries. Seventy-four point three percent self-identified as White, 8.3% Black, 2.4% Asian, 5.3% Hispanic, 7.1% Mixed race, and 1.4% Native Hawaiian or other Pacific Islander. Moderate to extreme difficulties with sexual activity and desire were associated with more difficulty accessing dermatologic care and higher patient global assessment scores (<i>P</i> < .01 for all). Depression and anxiety were associated with moderate to extreme difficulties with sexual activity (<i>P</i> < .01). Of the participants who were previously pregnant, 15% (<i>n</i> = 79/526) reported that HS interfered with breastfeeding ability. The top barrier to care was believing nothing could be done for HS during pregnancy and breastfeeding.</p><p><strong>Limitations: </strong>Diagnosis and disease severity were self-reported and could not be verified.</p><p><strong>Conclusion: </strong>Impaired sexual health was associated with access to care limitations, increased disease activity, and comorbid depression and anxiety. Our findings underscore the need for guidance on safe HS therapies during pregnancy and breastfeeding.</p>","PeriodicalId":53478,"journal":{"name":"International Journal of Women''s Dermatology","volume":"12 2","pages":"e261"},"PeriodicalIF":3.0,"publicationDate":"2026-04-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13308921/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148347377","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Marked improvement in severe hidradenitis suppurativa following tirzepatide therapy: a case report.","authors":"Ghaida Bader Alqefari, Meshal M Alhameedy","doi":"10.1097/JW9.0000000000000257","DOIUrl":"10.1097/JW9.0000000000000257","url":null,"abstract":"","PeriodicalId":53478,"journal":{"name":"International Journal of Women''s Dermatology","volume":"12 2","pages":"e257"},"PeriodicalIF":3.0,"publicationDate":"2026-04-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13308910/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148347335","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Recognizing the diagnostic challenges of mammary Paget's disease: a case report.","authors":"Hiba A Mohammed, Farrukh Azmi, Leanne Avery, Valerie Harvey","doi":"10.1097/JW9.0000000000000259","DOIUrl":"10.1097/JW9.0000000000000259","url":null,"abstract":"","PeriodicalId":53478,"journal":{"name":"International Journal of Women''s Dermatology","volume":"12 1","pages":"e259"},"PeriodicalIF":3.0,"publicationDate":"2026-02-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12944123/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147328114","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"A comprehensive analysis of online patient educational materials for lichen sclerosus.","authors":"Jennifer Foster, Hannah R Chang, Melissa M Mauskar","doi":"10.1097/JW9.0000000000000251","DOIUrl":"10.1097/JW9.0000000000000251","url":null,"abstract":"","PeriodicalId":53478,"journal":{"name":"International Journal of Women''s Dermatology","volume":"12 1","pages":"e251"},"PeriodicalIF":3.0,"publicationDate":"2026-02-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12919739/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147273047","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}